JG
INBX

Jefferies Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Jefferies Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,000
Closed -$261K – 2205
2021
Q1 		$261K Buy
+13,000
New +$380K ﹤0.01% 1279

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group's INBX Position: Q2 2021 in Review

Jefferies Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2021, closing a stake of 13,000 shares — an estimated $261K sold.

Jefferies Group first reported a position in INBX in Q1 2021 and held it in 1 quarter. The position peaked at $261K in Q1 2021. 61 funds tracked by Wall St. Rank hold INBX as of Q2 2021.

  • Jefferies Group reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 13,000 Inhibrx, Inc. Common Stock shares in Q2 2021, an estimated $261K.
  • Jefferies Group first reported a position in Inhibrx, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Jefferies Group's Inhibrx, Inc. Common Stock position peaked at $261K in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.